Prakash Saha

Images in cardiovascular medicine. Complications after endoluminal stent grafting of a thoracic mycotic aneurysm.

The monocyte/macrophage as a therapeutic target in atherosclerosis.

Upregulation of hypoxia-inducible factor 1 alpha in local vein wall is associated with enhanced venous thrombus resolution.

Encapsulation of angiogenic monocytes using bio-spraying technology.

In vivo magnetization transfer and diffusion-weighted magnetic resonance imaging detects thrombus composition in a mouse model of deep vein thrombosis.

TIE2-expressing monocytes/macrophages regulate revascularization of the ischemic limb.

Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis.

Vascular remodeling and plaque vulnerability in a rabbit model of atherosclerosis: comparison of delayed-enhancement MR imaging with an elastin-specific contrast agent and unenhanced black-blood MR imaging.

Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis.

Suppression of angiogenic response in local vein wall is associated with reduced thrombus resolution.

Local accumulation of hypoxia-inducible factor 2 alpha during venous thrombus resolution.

Postsurgical Inflammation as a Causative Mechanism of Venous Thromboembolism.

Quantification of experimental venous thrombus resolution by longitudinal nanogold-enhanced micro-computed tomography.

Blood Oxygenation Level-Dependent CMR-Derived Measures in Critical Limb Ischemia and Changes With Revascularization.

Contemporary management of acute and chronic deep venous thrombosis.

The soluble urokinase plasminogen activator receptor and its fragments in venous ulcers.

Cancer-Associated Thrombosis: Regulatory Mechanisms and Emerging Directions.

Increased Vascular Permeability Measured With an Albumin-Binding Magnetic Resonance Contrast Agent Is a Surrogate Marker of Rupture-Prone Atherosclerotic Plaque.

Human venous valve disease caused by mutations in FOXC2 and GJC2.

Radiation-Induced DNA Damage in Operators Performing Endovascular Aortic Repair.

Cathelicidins prime platelets to mediate arterial thrombosis and tissue inflammation.

Response by Patel et al to Letter Regarding Article, "Radiation Induced DNA Damage in Operators Performing Endovascular Aortic Repair".

Two Year Outcome After Chronic Iliac Vein Occlusion Recanalisation Using the Vici Venous Stent.

Tropoelastin: A novel marker for plaque progression and instability.

TNF-α (Tumor Necrosis Factor-α).

Use of Computed Tomography and Magnetic Resonance Imaging in Central Venous Disease.

Choosing a Mouse Model of Venous Thrombosis.

Choosing a mouse model of venous thrombosis: a consensus assessment of utility and application.

Redox dysregulation in the pathogenesis of chronic venous ulceration.

Midterm outcomes in postpartum women following endovenous treatment for acute iliofemoral deep vein thrombosis.

Early outcomes using dedicated venous stents in the upper limb of patients with venous thoracic outlet syndrome: A single centre experience.

Paget-Schroetter syndrome: A contemporary review of the controversies in management.

Reactive Oxygen Species in Venous Thrombosis.

Device profile of the Vici venous stent for chronic iliofemoral venous obstruction recanalization: overview of its safety and efficacy.

AngioJet Pharmacomechanical Thrombectomy and Catheter Directed Thrombolysis vs. Catheter Directed Thrombolysis Alone for the Treatment of Iliofemoral Deep Vein Thrombosis: A Single Centre Retrospective Cohort Study.

Effect of thrombophilia on clinical outcomes of chronic post-thrombotic patients after iliofemoral stenting with nitinol venous stents.

Quality of life outcomes for patients undergoing venous stenting for chronic deep venous disease.

Vascular access support teams: A multi-disciplinary response to optimise patient care during the COVID-19 pandemic.

Mutations in EPHB4 cause human venous valve aplasia.

Medium-term outcomes after inferior vena cava reconstruction for acute and chronic deep vein thrombosis and retroperitoneal fibrosis.

A Systematic Review and Meta-Analysis of 12-Month Patency After Intervention for Iliofemoral Obstruction Using Dedicated or Non-Dedicated Venous Stents.